Literature DB >> 26359290

Multiple sclerosis associated genetic variants of CD226 impair regulatory T cell function.

Melanie Piédavent-Salomon1, Anne Willing1, Jan Broder Engler2, Karin Steinbach2, Simone Bauer2, Britta Eggert2, Friederike Ufer2, Nina Kursawe2, Sabine Wehrmann2, Jan Jäger2, Stefanie Reinhardt2, Manuel A Friese2.   

Abstract

Recent association studies have linked numerous genetic variants with an increased risk for multiple sclerosis, although their functional relevance remains largely unknown. Here we investigated phenotypical and functional consequences of a genetic variant in the CD226 gene that, among other autoimmune diseases, predisposes to multiple sclerosis. Phenotypically, effector and regulatory CD4(+) memory T cells of healthy individuals carrying the predisposing CD226 genetic variant showed, in comparison to carriers of the protective variant, reduced surface expression of CD226 and an impaired induction of CD226 after stimulation. This haplotype-dependent reduction in CD226 expression on memory T cells was abrogated in patients with multiple sclerosis, as CD226 expression was comparable to healthy risk haplotype carriers irrespective of genetic variant. Functionally, FOXP3-positive regulatory T cells from healthy carriers of the genetic protective variant showed superior suppressive capacity, which was again abrogated in multiple sclerosis patients. Mimicking the phenotype of human CD226 genetic risk variant carriers, regulatory T cells derived from Cd226-deficient mice showed similarly reduced inhibitory activity, eventually resulting in an exacerbated disease course of experimental autoimmune encephalomyelitis, the animal model of multiple sclerosis. Therefore, by combining human and mouse analyses we show that CD226 exhibits an important role in the activation of regulatory T cells, with its genetically imposed dysregulation impairing regulatory T cell function.
© The Author (2015). Published by Oxford University Press on behalf of the Guarantors of Brain. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  CD226; autoimmunity; multiple sclerosis; regulatory T cells

Mesh:

Substances:

Year:  2015        PMID: 26359290     DOI: 10.1093/brain/awv256

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  9 in total

1.  Reply to Liu et al.: Haplotype matters: CD226 polymorphism as a potential trigger for impaired immune regulation in multiple sclerosis.

Authors:  Catharina C Gross; Gerd Meyer Zu Hörste; Andreas Schulte-Mecklenbeck; Luisa Klotz; Sven G Meuth; Heinz Wiendl
Journal:  Proc Natl Acad Sci U S A       Date:  2017-01-30       Impact factor: 11.205

2.  TIGIT signaling restores suppressor function of Th1 Tregs.

Authors:  Liliana E Lucca; Pierre-Paul Axisa; Emily R Singer; Neal M Nolan; Margarita Dominguez-Villar; David A Hafler
Journal:  JCI Insight       Date:  2019-02-07

3.  Evaluation of the safety and immunomodulatory effects of sargramostim in a randomized, double-blind phase 1 clinical Parkinson's disease trial.

Authors:  Howard E Gendelman; Yuning Zhang; Pamela Santamaria; Katherine E Olson; Charles R Schutt; Danish Bhatti; Bhagya Laxmi Dyavar Shetty; Yaman Lu; Katherine A Estes; David G Standaert; Elizabeth Heinrichs-Graham; LuAnn Larson; Jane L Meza; Matthew Follett; Erica Forsberg; Gary Siuzdak; Tony W Wilson; Carolyn Peterson; R Lee Mosley
Journal:  NPJ Parkinsons Dis       Date:  2017-03-23

4.  Vitamin D/CD46 Crosstalk in Human T Cells in Multiple Sclerosis.

Authors:  Justin Killick; Joanne Hay; Elena Morandi; Sonja Vermeren; Saniya Kari; Thibault Angles; Anna Williams; Jan Damoiseaux; Anne L Astier
Journal:  Front Immunol       Date:  2020-11-24       Impact factor: 7.561

5.  Evaluation of Age-Dependent Immune Signatures in Patients With Multiple Sclerosis.

Authors:  Melanie Eschborn; Marc Pawlitzki; Timo Wirth; Christopher Nelke; Steffen Pfeuffer; Andreas Schulte-Mecklenbeck; Lisa Lohmann; Leoni Rolfes; Katrin Pape; Maria Eveslage; Stefan Bittner; Catharina C Gross; Tobias Ruck; Heinz Wiendl; Sven G Meuth; Luisa Klotz
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-10-19

Review 6.  Natural Killer Cells in Multiple Sclerosis: Entering the Stage.

Authors:  Jarne Beliën; An Goris; Patrick Matthys
Journal:  Front Immunol       Date:  2022-04-06       Impact factor: 8.786

Review 7.  Recognition and Regulation of T Cells by NK Cells.

Authors:  Katharina Pallmer; Annette Oxenius
Journal:  Front Immunol       Date:  2016-06-24       Impact factor: 7.561

8.  Rotating magnetic field ameliorates experimental autoimmune encephalomyelitis by promoting T cell peripheral accumulation and regulating the balance of Treg and Th1/Th17.

Authors:  Tianying Zhan; Xiaomei Wang; Zijun Ouyang; Youli Yao; Jiangyao Xu; Shikang Liu; Kan Liu; Qiyu Deng; Yushu Wang; Yingying Zhao
Journal:  Aging (Albany NY)       Date:  2020-04-07       Impact factor: 5.682

9.  The Role of Hemoglobin Subunit Delta in the Immunopathy of Multiple Sclerosis: Mitochondria Matters.

Authors:  Afshin Derakhshani; Hossein Safarpour; Mahdi Abdoli Shadbad; Nima Hemmat; Patrizia Leone; Zahra Asadzadeh; Mehrdad Pashazadeh; Behzad Baradaran; Vito Racanelli
Journal:  Front Immunol       Date:  2021-08-24       Impact factor: 7.561

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.